Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 858 of 6351
-
New radioactive 'Smart Bomb' targets Hard-to-Treat cancers
Disease control Recruiting nowThe main purpose of Part A of the study is to evaluate safety, tolerability and tracer uptake after a single intravenous (IV) administration of \[68Ga\]Ga-DPI-4452 for each tumor type such as clear cell renal cell cancer (ccRCC), pancreatic ductal adenocarcinoma (PDAC), and color…
Phase 1/2 • Sponsor: Lumara Bio Oncologics GmbH • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
Can a simple pill save Insulin-Making cells in type 1 diabetes?
Disease control OngoingThe goal of this clinical trial is to test a drug known as DFMO in people with Type 1 Diabetes (T1D). The main question\[s\] it aims to answer are: * Does it reduce stress on the cells that make insulin? * Does it preserve what is left of the body's insulin production? Participa…
Phase 2 • Sponsor: Emily K. Sims • Aim: Disease control
Last updated Aug 23, 2026 00:00 UTC
-
New combo therapy targets Hard-to-Treat stomach cancer
Disease control Recruiting nowThis is an open,multicentre phase Ib/II study. The purpose of phase Ib is to evaluated the safety, tolerability, pharmacokinetics, immunogenicity, and preliminary antitumor activity of SHR-A1811 in combination with chemotherapy and/or immunotherapy in HER2 expression advanced/met…
Phase 2 • Sponsor: Suzhou Suncadia Biopharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
New combo aims to outdo chemo for tough lung cancers
Disease control OngoingThis phase III trial compares the effect of the combination of ramucirumab and pembrolizumab versus standard of care chemotherapy for the treatment of non-small cell lung cancer that is stage IV or that has come back after a period of improvement (recurrent). Ramucirumab is a mon…
Phase 3 • Sponsor: SWOG Cancer Research Network • Aim: Disease control
Last updated Jun 27, 2026 12:09 UTC
-
Can retraining the Brain's food cues help teens with anorexia?
Disease control Recruiting nowThis project includes a parallel group randomized controlled trial comparing two psychological treatments: 1) Exposure-based Family Therapy (IE) vs. 2) Family Based Therapy (FBT) for low weight eating disorders with 12 month follow-up. Primary outcomes are expected body weight an…
Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Can a common antibiotic beat yaws? new trial puts linezolid to the test
Disease control CompletedThe goal of this clinical trial is to test the non inferiority of linezolid compared with azithromycin as a treatment for yaws . The main questions it aims to answer are: can linezolid cure active yaws, and can linezolid cure latent yaws. Participants with serologically confirmed…
Phase 3 • Sponsor: Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
Double brain zapping: could two stimulation methods beat depression?
Disease control Recruiting nowThe purpose of the research is to test out a combined treatment for depression where the investigators stimulate a nerve in the ear while at the same time stimulate the brain with magnets. These treatments are called transcutaneous (through the skin) auricular (ear) vagus nerve s…
Sponsor: Medical University of South Carolina • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
New gel could outperform standard therapy for kidney disease
Disease control Recruiting nowThe goal of the Phase 3a part of this clinical trial is to determine the optimal dose that will be used in the Phase 3b part of this clinical trial. The goal of the Phase 3b part is to assess the efficacy of SNP-ACTH (1-39) Gel relative to rituximab in patients with primary membr…
Phase 3 • Sponsor: Cerium Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
New hope for head and neck cancer: Three-Drug showdown after immunotherapy fails
Disease control OngoingThis phase II/III compares the standard therapy (chemotherapy plus cetuximab) versus adding bevacizumab to standard chemotherapy, versus combination of just bevacizumab and atezolizumab in treating patients with head and neck cancer that has spread to other places in the body (me…
Phase 2/3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Aug 02, 2026 00:00 UTC
-
Gene-Edited immune cells take on Hard-to-Treat cancers
Disease control CompletedThis is an open-label, multicenter, Phase 1/2 study evaluating the safety and efficacy of CTX131™ in subjects with relapsed or refractory solid tumors.
Phase 1/2 • Sponsor: CRISPR Therapeutics AG • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
Could a smartphone app curb childhood obesity? a new study tests two rollout strategies
Prevention OngoingMINISTOP is an evidence-based app for parents of preschool aged children with the overall aim to promote healthy lifestyle behaviors and prevent the development of overweight and obesity. MINISTOP has been previously been evaluated in two previous trials (MINISTOP 1.0 and 2.0) wi…
Sponsor: Karolinska Institutet • Aim: Prevention
Last updated Aug 14, 2026 00:00 UTC
-
New cream offers hope for unbearable itch
Symptom relief CompletedThe purpose of this study is to evaluate the safety and tolerability of Ruxolitinib cream in participants with Prurigo Nodularis (PN).
Phase 3 • Sponsor: Incyte Corporation • Aim: Symptom relief
Last updated Aug 14, 2026 00:00 UTC
-
New eczema drug shows promise for kids in Long-Term trial
Disease control By invitation onlyThe main purpose of this study is to assess the long-term safety and efficacy of lebrikizumab in participants 6 Months to \<18 years of age with moderate-to-severe atopic dermatitis. This study will last about 68 weeks and may include up to 16 planned visits. If participating in…
Phase 3 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Aug 01, 2026 00:00 UTC
-
New heart device aims to zap away irregular rhythm
Disease control OngoingThis study will evaluate the safety and effectiveness of the Globe® Pulsed Field System for treating patients with symptomatic paroxysmal or persistent atrial fibrillation (AF).
Sponsor: Kardium Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
New nasal vaccine aims to protect kids from RSV
Vaccine Recruiting nowThis Phase 1/2a trial is a randomized, placebo-controlled trial to evaluate the safety, tolerability and immunogenicity of two ascending doses (10\^6 PFU and 10\^7 PFU) of intranasal BLB-201 (a recombinant parainfluenza virus type 5) administered in infants (8-24 months of age) a…
Phase 1/2 • Sponsor: Blue Lake Biotechnology Inc. • Aim: Vaccine
Last updated Jul 31, 2026 00:00 UTC
-
Aspirin may shield new moms from breast cancer
Prevention Recruiting nowThis phase II trial tests whether low-dose aspirin can affect markers of inflammation in postpartum (after childbirth) women planning to have a breast biopsy. Chronic inflammation may increase the risk of postpartum related breast cancer. Low-dose aspirin is a non-steroidal anti-…
Phase 2 • Sponsor: Mayo Clinic • Aim: Prevention
Last updated Aug 22, 2026 00:00 UTC
-
New combo therapy aims to shrink tough liver tumors
Disease control Recruiting nowAtezolizumab and bevacizumab was approve for advanced unresectable hepatocellular carcinoma (aHCC). Whether the additional of transartial chemobolization and hepatic artery infusion chemotherapy will improve the response rate for those patients is still unknown. This phase 2 clin…
Phase 2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
Can a flash of radiation ease bone pain in seconds?
Symptom relief OngoingThe purpose of this study is to assess toxicities of FLASH radiotherapy treatment and pain relief in subjects with painful thoracic bone metastases. FLASH radiotherapy is radiation treatment delivered at ultra-high dose rates compared to conventional radiation treatment.
Sponsor: Varian, a Siemens Healthineers Company • Aim: Symptom relief
Last updated Aug 21, 2026 00:00 UTC
-
New hope for kids with tough leukemia: antibody drug tafasitamab enters trial
Disease control Recruiting nowThe objective of the trial is to evaluate the safety, clinical toxicity and in vivo immunological effects of MOR00208 in pediatric patients with acute lymphoblastic leukemia who showed newly emerging or persistent MRD after a first stem cell transplantation, received stem cell tr…
Phase 1/2 • Sponsor: University Hospital Tuebingen • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
Brain scans may reveal hidden signs of consciousness after severe injury
Knowledge-focused By invitation onlyThe goal of this study is to determine the extent to which neuroimaging metrics (e.g., functional MRI) are associated with the current level of consciousness, and future consciousness recovery, in patients with disorders of consciousness resulting from acute brain injury. The mai…
Sponsor: University of Pennsylvania • Aim: Knowledge-focused
Last updated Aug 01, 2026 00:00 UTC